Decoding the mitochondria without a code: mechanistic insights into mitochondrial DNA depletion syndromes

Area of Science:

• Genetics and Molecular Biology
• Cellular Biology
• Rare Diseases

Background:

• Mitochondrial DNA depletion syndromes (MDS) are a group of rare genetic disorders characterized by a significant reduction in mitochondrial DNA (mtDNA).
• These syndromes present with diverse clinical phenotypes, including myopathic, encephalomyopathic, hepatocerebral, and neurogastrointestinal manifestations.
• Current management relies heavily on symptomatic treatment and nutritional support, with a poor overall prognosis.

Approach:

• This review synthesizes current understanding of the proposed mechanistic underpinnings of mtDNA depletion.
• It examines the latest advancements in therapeutic strategies for MDS.
• The focus is on moving beyond palliative care towards targeted organelle-based interventions.

Key Points:

• MDS pathogenesis involves complex genetic factors leading to impaired mtDNA maintenance.
• Phenotypic heterogeneity underscores the systemic impact of mitochondrial dysfunction.
• Understanding disease mechanisms is crucial for developing effective treatments.

Conclusions:

• A deeper comprehension of mtDNA depletion mechanisms is essential for advancing MDS treatment.
• Emerging therapies aim to restore mitochondrial function and address the root cause of MDS.
• The future of MDS management lies in targeted, organelle-focused therapeutic approaches.